Empowering Bladder Cancer Patients Through New Partnerships
Transformative Partnerships for Bladder Cancer Awareness
In a significant move to enhance the fight against bladder cancer, the Bladder Cancer Advocacy Network (BCAN) has announced its collaboration with Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as National Presenting Sponsors for the upcoming Walks to End Bladder Cancer. These strategic partnerships are set to not only amplify awareness but also generate essential funding aimed at advancing bladder cancer research and providing vital support for patients and their families.
Commitment to Patients and Their Families
Meri-Margaret Deoudes, the CEO of BCAN, expressed enthusiasm about the new partnerships. She stated, “We are excited to welcome Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as our National Presenting Sponsors. This collaboration is instrumental in furthering our mission to support patients and families affected by bladder cancer, allowing us to create a more significant impact in the battle against this disease.”
Overview of the Walks to End Bladder Cancer
The annual Walks to End Bladder Cancer are pivotal events organized by BCAN, taking place in various cities across the country. These events are designed not only to raise awareness about bladder cancer but also to unite communities and encourage participation during Bladder Cancer Awareness Month, which takes place in May. In 2025, there are plans for 19 Walk locations, promising an opportunity for thousands to come together and spread awareness about this vital cause.
Ferring Pharmaceuticals' Dedication to Uro-Oncology
The Vice President of Ferring Pharmaceuticals, David Bell, articulated the company's dedication saying, “Ferring is proud to support the bladder cancer community as a national presenting sponsor of the Walks to End Bladder Cancer. Our commitment is driven by the need to bring hope to patients and families, and to advance research that can lead to better outcomes.”
Collaboration for a Greater Cause
The alliances formed between BCAN, Ferring Pharmaceuticals, and the Astellas/Pfizer Alliance underscore a mutual goal: empowering individuals affected by bladder cancer while simultaneously propelling forward bladder cancer research. These organizations are dedicated to transforming bladder cancer care and fostering hope within the affected community.
About BCAN and Its Mission
The Bladder Cancer Advocacy Network, founded in 2005, is committed to supporting bladder cancer patients by providing crucial information and facilitating community support. Furthermore, BCAN actively promotes innovative research and advocates for responsive national policies that can inspire hope for the future of those living with bladder cancer.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a leading biopharmaceutical organization focused on building families and enhancing lives through innovative solutions. Known for its leadership in uro-oncology, Ferring is also recognized in reproductive medicine, gastroenterology, and orthopaedics. Founded in 1950 and headquartered in Switzerland, Ferring operates globally, employing over 7,000 professionals.
About Astellas and Pfizer
Astellas is dedicated to transforming innovative science into valuable healthcare solutions across diverse fields including oncology and women’s health. Similarly, Pfizer is committed to improving health globally by applying science and resources to develop innovations that significantly enhance life quality.
Frequently Asked Questions
What is the purpose of the Walks to End Bladder Cancer?
The Walks to End Bladder Cancer aim to raise awareness about bladder cancer, bringing together communities to support patients and families affected by this disease.
How can I participate in the Walks?
Participants can find a Walk location near them through the BCAN website and join in to support the initiative and raise awareness.
What organizations are sponsoring the Walks?
The Walks to End Bladder Cancer are sponsored by Ferring Pharmaceuticals and the Astellas/Pfizer Alliance.
Who can benefit from BCAN's resources?
BCAN provides support and resources primarily for bladder cancer patients and their families, offering critical information to help them navigate their health journeys.
What is BCAN's mission?
BCAN's mission is to provide support and resources for bladder cancer patients while advocating for research and effective policies to improve care and outcomes.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
